Part-Time
Group-based weight loss program with meetings
CA$15 - CA$20/hr
Barrie, ON, Canada
In Person
Friday mornings in Midland, ON 8am-10am; opportunities to sub in nearby area.
See people who can refer or advise you
Weight Watchers runs a weight management program centered on group support and accountability. Members join meetings for guidance, share tips, and track progress as part of a community that helps people manage eating and activity habits rather than promoting a single diet. The program typically involves paying a weekly or regular fee for in-person or virtual meetings, plus related products and materials that support behavior change. It differentiates itself from competitors by emphasizing a social, ongoing support system and a structured points-based approach to eating that members follow within a community framework, rather than relying on short-term diet plans. The company’s goal is to help people achieve healthier weight and lifestyles through long-term, sustainable changes supported by a network of peers and coaches.
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
New York City, New York
Founded
1963
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Flexible Work Hours
Hybrid Work Options
WeightWatchers reported Q2 revenues of $162.3 million, down 14.2% year-on-year but exceeding analyst expectations by 2%. The wellness company beat EPS estimates but missed EBITDA projections in what was deemed a satisfactory quarter. Despite the relatively good results, WeightWatchers delivered the weakest full-year guidance update among nine consumer discretionary specialised consumer services stocks tracked. The sector as a whole underperformed in Q2, with revenues missing consensus estimates by 0.7%. The market reacted negatively to WeightWatchers' outlook. Shares fell 8.4% following the earnings announcement and currently trade at $14.12. Consumer discretionary specialised consumer services stocks have declined 4.6% on average since their latest earnings results.
WeightWatchers reported second-quarter revenue of $162.3 million, beating analyst estimates of $159.1 million despite a 14.2% year-on-year decline. The company posted earnings per share of $1.41, significantly above the $0.67 estimate. Management highlighted a strategic shift towards higher-value membership tiers and clinical offerings, with growth in Core+ and Med+ subscribers offsetting declines in traditional behavioural segments. Interim Chief Operations Officer Jonathan Volkmann noted the company's approach combines FDA-approved GLP-1 medications with expert guidance. The company reaffirmed full-year revenue guidance of $627.5 million and EBITDA guidance of $110 million. Operating margin fell to 8.1% from 28.1% in the prior year quarter. No analyst question-and-answer session occurred during the earnings call.
WW International reported Q2 2026 revenue of $162.3 million, down from $189.2 million the previous year. Clinical subscription revenue grew 30.4% year-over-year to $39.9 million, now representing 24.6% of total revenue. Clinical subscribers reached 197,000, up 55.7% annually. The company's Core+ tier showed momentum with 541,000 subscribers, up 13.9% year-over-year, marking three consecutive quarters of sequential growth. However, total subscribers fell 24.6% to 2.3 million due to weakness in the Core tier. WW reported net income of $14.1 million and adjusted EBITDA of $39.8 million with a 24.5% margin. The company generated $24.3 million in operating cash flow and reduced its term loan to $423.6 million, down over 70% from $1.6 billion before reorganisation. Management reaffirmed full-year 2026 guidance of $620-635 million in revenue and $105-115 million adjusted EBITDA.
WeightWatchers reported second quarter revenue of $162.3 million, beating analyst estimates of $159.1 million but falling 14.2% year-on-year. The personal wellness company posted GAAP earnings of $1.41 per share, significantly exceeding the $0.67 consensus estimate. The company maintained its full-year revenue guidance of $627.5 million at the midpoint, which came in 0.7% below analyst expectations. EBITDA guidance of $110 million surpassed estimates of $107.9 million. Operating margin declined to 5.8% from 32.3% in the prior-year quarter. Free cash flow improved to $30.06 million, up from negative $38 million year-on-year. WeightWatchers has struggled with declining demand, with revenue falling at a 12.4% annual rate over the past five years. Analysts forecast revenue will decline 6.2% over the next 12 months.
WeightWatchers will report its second-quarter earnings on Wednesday after market close. The market expects the company's revenue to decline 15.9% year on year, a further deceleration from the 6.4% decrease it recorded in the same quarter last year. In the first quarter, WeightWatchers beat revenue expectations with $168.3 million, down 9.8% year on year. However, the company significantly missed analysts' EBITDA and EPS estimates. Analysts covering WeightWatchers have generally reconfirmed their estimates over the last 30 days. The company has missed Wall Street's revenue estimates multiple times over the last two years. Shares are currently trading at $16.05, below the average analyst price target of $28.33.